Literature DB >> 14646159

Autoimmune hemolytic anemia associated with benign ovarian cyst: a case report and review of literature.

V Agarwal1, A Sachdev, R Singh, S Lehl, S Basu.   

Abstract

A 28-years-old female presented with severe autoimmune hemolytic anemia (AIHA), warm antibody mediated, and right side tubo-ovarian (TO) mass. There was sub-optimal response to immunosuppressive therapy (IST). Eight months later she underwent ovarian cystectomy which resulted in complete remission of AIHA without the need for IST. Pathological examination of the TO mass revealed benign ovarian cyst. Our case highlights the need to search for ovarian cyst/mass in females presenting with AIHA. Since immunosuppressive therapy is usually ineffectual in AIHA associated with ovarian cyst, it may be appropriate to contemplate surgery before embarking on IST in such cases.

Entities:  

Mesh:

Year:  2003        PMID: 14646159

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  4 in total

1.  Warm antibody autoimmune haemolytic anaemia associated with ovarian teratoma.

Authors:  Pedro Oliveira Raimundo; Susana Coelho; Alexandra Cabeleira; Luis Dias; Manuela Gonçalves; Julio Almeida
Journal:  BMJ Case Rep       Date:  2010-05-19

2.  Hepatocellular carcinoma with chronic B-type hepatitis complicated by autoimmune hemolytic anemia: a case report.

Authors:  Toshie Okada; Keiichi Kubota; Junji Kita; Masato Kato; Tokihiko Sawada
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

Review 3.  The role of iron in the skin and cutaneous wound healing.

Authors:  Josephine A Wright; Toby Richards; Surjit K S Srai
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

4.  Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery.

Authors:  Antonio Macciò; Clelia Madeddu; Paraskevas Kotsonis; Michele Pietrangeli; Anna Maria Paoletti
Journal:  BMC Surg       Date:  2014-06-24       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.